# Study of GS-5319 in Adults With Solid Tumors

> **NCT07128303** · PHASE1 · RECRUITING · sponsor: **Gilead Sciences** · enrollment: 178 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** GS-5319

## Key facts

- **NCT ID:** NCT07128303
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-28
- **Primary completion:** 2028-05
- **Final completion:** 2028-05
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07128303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07128303, "Study of GS-5319 in Adults With Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07128303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*